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Abstract 
 
Background: Sleep disordered breathing (SDB) occurs in over half of the estimated 5.1 million 
people in the U.S. diagnosed with heart failure (HF). Evidence shows that treatment of SDB in 
this population decreases not only morbidity and mortality rates, but the overall cost burden of 
the disease as well. The routine use of a sleep apnea screening protocol in the HF population can 
help identify patients in need of treatment. Methods: A project was conducted at an urban 
community heart failure clinic to evaluate provider preference of three evidence-based screening 
tools to be included in the implementation of a comprehensive SDB screening protocol. This 
project’s long-term goal was to design and implement a SDB protocol for heart failure patients 
treated at an urban heart failure clinic using the Health Belief Model. Results: Providers chose 
the Epworth Sleepiness Scale (ESS) as the screening questionnaire to be used in the final 
screening protocol. Conclusion: Ease of use, sensitivity within patient population, and patient-
friendly format were cited as the deciding factors for provider choice of the ESS as the preferred 
screening tool.  
Keywords: sleep apnea, screening, heart failure, protocol, questionnaire 
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Screening for Sleep Apnea in the Heart Failure Population 
According to the Centers for Disease Control (CDC), approximately 5.1 million people in 
the United States have a diagnosis of heart failure (HF) and half will die within five years of 
diagnosis (Centers for Disease Control and Prevention Website, 2013). Heart failure, as a 
syndrome, is thus characterized by its high mortality as well as frequent hospitalizations and a 
reduced quality of life. Estimates put total heart failure costs to the nation at a staggering $37 
billion each year (Brenner, Angermann, Jany, Ertl, & Stork, 2008; Centers for Disease Control 
and Prevention Website, 2013). Decreasing such costs, in addition to improving morbidity and 
mortality, hinges upon identifying those factors that impact not only the treatment but also the 
progression of the condition. Sleep-disordered breathing, commonly known as sleep apnea, is the 
most common comorbidity in HF, occurs in 50-80% of patients, and is known to accelerate the 
progression of the condition thus increasing morbidity and mortality (Kasai & Bradley, 2011; 
Khayat et al., 2013).  Sleep apnea is defined as a combination of hypopnea (slow, shallow 
breathing for 10 seconds or more) and apnea (cessation of breathing for 10 seconds or more) that 
results in a decrease in blood oxygen saturation (Spieker & Motzer, 2003).  
Several types of sleep-disordered breathing have been identified in the heart failure 
population. They include obstructive sleep apnea, central sleep apnea, and complex sleep apnea 
syndrome, which has characteristics of both the afore-mentioned types. Obstructive sleep apnea 
affects approximately 35% of HF patients and is caused by partial or complete collapse or 
obstruction of the upper airway. When obstructive sleep apnea is present in the HF patient, the 
change in intra-thoracic pressure and an increased sympathetic drive are the pathophysiologic 
mechanisms that affect the progression of HF. Apneic and hypopneic events in obstructive sleep 
apnea result in a cascade of neuro-humoral changes such as decreased cardiac output, increased 
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myocardial oxygen demand, vasoconstriction, hypertension, and activation of the renal renin-
angiotensin system (Khayat et al., 2013). Over time, such pathology contributes to ventricular 
hypertrophy, cardiac remodeling, and failure and significantly adds to the risk of myocardial 
ischemia, arrhythmias, hypertension, and worsening ventricular dysfunction. Central sleep apnea 
is more complex and more difficult to treat, as its cause is the temporary withdrawal of the 
brainstem-driven respiratory drive. A distinct pattern of breathing, termed Cheyne-Stokes 
respiration, is characterized by central apnea or hypopnea that is then followed by 
hyperventilation in a cyclic crescendo-decrescendo pattern. The resulting oscillation of increased 
arterial carbon dioxide and decreased arterial carbon dioxide above and below the apneic 
threshold is thought to be the cause.  
Patients with reduced left ventricular ejection fraction (LVEF) have the greatest 
incidence of central sleep apnea, 30-50%, whereas those with preserved LVEF present with this 
type in only 18-30% of cases. Much like the obstructive type, patients with central sleep apnea 
and HF experience the neuro-humoral and hemodynamic changes that are detrimental to the 
failing heart. (Khayat et al., 2013). There is accumulating research evidence that nocturnal 
breathing disorders are important modifiers of disease progression in patients with HF (Brenner 
et al., 2008). Identification and treatment of sleep apnea in the HF population is critical to 
improving the outcomes and overall impact of this widely prevalent cardiovascular disorder. 
Literature Review 
A comprehensive review of the literature was conducted with the keywords heart failure, 
sleep apnea, treatment, and screening using CINAHL and PubMed. Results were narrowed to 
include only work published within the last eight years for CINAHL and the last five years for 
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PubMed and resulted 92 and 128 items respectively. Only research studies that evaluated apnea 
screening and/or treatment were reviewed.  
Sixteen studies were selected for inclusion in this review: three meta-analyses, five 
randomized control trials (RCTs), two quasi-experimental studies, two prospective observational 
study, two post hoc study analyses, one systematic review, and one retrospective chart review. 
All studies were critically appraised by type of evidence as well as strength and consistency 
using the Jacox Model and were found to be of high quality. Three major treatment modalities 
and three screening tools emerged for both types of sleep-disordered breathing and their findings 
summarized. 
Continuous Positive Airway Pressure (CPAP) 
Providing continuous airway support in patients with sleep apnea has been found to 
improve the AHI in sleep apneic patients in general. Five studies examined the effects of CPAP - 
continuous, low-level end-expiratory pressure that helps maintain an open airway - as treatment 
for sleep-disordered breathing in the heart failure patient. Sun et al. (2013), a meta-analysis of 
ten RCTs and Jacox 1A study, determined that CPAP may improve LVEF by 3.59% in patients 
with obstructive sleep apnea. However, CPAP was found to increase LVEF by 5.18% in those 
patients with obstructive sleep apnea and documented heart failure. Ferrier et al. (2008), Jacox 
IIA, also evaluated the effect of CPAP in HF patients with obstructive sleep apnea over six 
months using a 26-patient RCT.  
Left ventricular function (LVEF) was again improved with CPAP, as well as other 
measures of physiologic improvement such as decreased systolic blood pressure and decreased 
left ventricular end-systolic volume. Hall et al. (2014), Jacox IIB, and Kasai et al. (2008), Jacox 
IIB, also reported findings that support the use of CPAP in the obstructive sleep apnea/HF 
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population by improving cardiac efficiency and reducing the risk of hospitalization and death 
respectively. One study assessed the use of CPAP in the presences of central sleep apnea. This 
post hoc analysis of the Canadian Continuous Positive Airway Pressure Trial by Arzt et al. 
(2007) concluded that suppression of central sleep apnea soon after its initiation with CPAP may 
not only improve LVEF but also heart transplant-free survival. 
Bi-level Positive Airway Pressure (BiPAP) 
BiPAP adds additional respiratory support to the existing CPAP via a set level of 
inspiratory pressure administered with each breath.  One RCT evaluated the use of BiPAP in 
SDB. Khayat et al. (2008), Jacox IIC, compared the use of CPAP in treatment of obstructive 
sleep apnea to the use of BiPAP in improving LVEF in 24 patients with stable systolic 
dysfunction HF and newly diagnosed sleep apnea. The study found BiPAP to be superior to 
CPAP in increasing left ventricular function in this HF population, raising LVEF 7.9% more than 
CPAP although both methods were effective in reducing the apnea-hypopnea index (AHI).  
This was the first study to compare BiPAP vs. CPAP for obstructive sleep apnea in 
patients with systolic dysfunction thus it had several limitations. Most notably, limited 
measurements such as echocardiogram that precluded a thorough assessment of the impact of 
BiPAP on cardiovascular parameters. Larger studies with greater hemodynamic measure would 
aide in the stronger conclusion of BiPAP superiority. 
Adaptive Servoventilation (ASV) 
Adaptive servoventilation, also known as dynamic BiPAP, is a method of respiratory 
support that adjusts the inspiratory support component according to the needs of the patient. 
Although CPAP has been shown to reduce AHI, increase LVEF, and reduce sympathetic activity 
in HF patients with SDB, it has been unsuccessful in suppressing CSA in nearly 50% of treated 
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patients (Sharma et al., 2012). The research supports the use of ASV for the suppression of CSA 
as well as mixed apneas (CompSAS) in the heart failure patient. Arzt et al. (2008), a quasi-
experimental Jacox IIIB study, studied 14 CHF patients with CSR-CSA for three nights – one for 
a baseline sleep study, one for CPAP or BiPAP support, and one for ASV support. Although 
CPAP or BiPAP reduced AHI, ASV was found to have the greatest reduction in AHI and thus 
CSA suppression.  
Similarly, Joho et al. (2012), another quasi-experimental Jacox IIIB study, found that 
ejection fraction and muscle sympathetic nerve activity (MSNA) changed significantly in the 
ASV group studied vs. the non-ASV group and concluded that ASV decreases MSNA, improves 
cardiac function, and suppresses central sleep apnea in HF patients. Allam et al. (2007) 
performed a retrospective chart review of 100 patients who had a sleep study using ASV at Mayo 
Clinic Sleep Center. Although this is Jacox VB evidence, the authors concluded that the ASV 
method of ventilator support appeared to be effective in treating both complex sleep apnea 
syndrome and central sleep apnea syndromes previously resistant to CPAP therapy.  
Those findings were reinforced by the RCT study, Jacox IIB evidence, by Randerath et 
al. (2012) of 70 patients with HF and the coexistence of obstructive and central sleep apnea 
confirmed ASV improved CSR-CSA more effectively than CPAP as well as BNP over a twelve-
month period. Owada et al. (2013) found that ASV also had an effect on cardiorenal function in 
HF patients with CKD and SDB in their prospective observational study of 80 patients. This 
Jacox IVB study reinforces the additive benefits of ASV support in the presence of central sleep 
apnea and its effects on HF.  
Lastly, Sharma et al. (2012) published the highest quality evidence in support of ASV for 
treatment of sleep apnea in heart failure. Their systematic review and meta-analysis, Jacox 1A 
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evidence, found that ASV for sleep apnea not only reduced AHI, but also improved cardiac 
function and exercise capacity (a factor that has the ability to change NYHA classification of 
HF).  
Screening Tools 
Several screening tools have been designed to identify sleep apnea in a variety of 
populations. A review of the literature with specific emphasis on diagnosing sleep apnea in the 
heart failure population revealed three tools most commonly used: the Epworth Sleepiness Scale 
(ESS), the STOP-Bang Equivalent Model, and the Berlin Questionnaire. (Appendices 1-3) 
A retrospective chart review by Rosenthal & Dolan (2008) to assess the sensitivity of the 
ESS in identifying obstructive sleep apnea was conducted on 268 patients screened using this 
evaluation tool. Patients were screened using the ESS and then underwent a polysomnography 
(PSG) study to measure the AHI. ESS scores were analyzed in comparison to AHI greater than 
or equal to five (the diagnostic criteria for sleep apnea). This Jacox V-B study determined that 
the ESS alone has a fair discriminatory ability as a screener for obstructive sleep apnea when 
using a cutoff score of ten (66% sensitivity) but sensitivity of the screen improves (76%) when a 
lower score of eight is used.  
Farney et al. (2011) conducted a similar study using the STOP-Bang Equivalent model 
(SBM) and its ability to predict obstructive sleep apnea in comparison to the PSG and measured 
AHI in an effort to further classify obstructive sleep apnea into categories ranging from none to 
severe. A Jacox V-B rated study, the authors used three statistical models to compare the STOP-
Bang scores of 1,426 patients who underwent PSG and analyzed the data. Based on the results, 
stratification of sleep apnea severity based on STOP-Bang scoring was determined. For example, 
a patient with a SBM score of 6-8 has a high probability of being diagnosed with obstructive 
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sleep apnea via PSG (53.3%, 74.1%, and 81.9%, respectively) and further evaluation would be 
recommended.  
The Berlin Questionnaire (BQ), as a sleep apnea screening tool, also underwent testing to 
evaluate the sensitivity and specificity of this screen in comparison to the gold standard PSG as a 
diagnostic tool.  Netzer et al. (1999) was the first to evaluate the use of a screening tool for sleep 
apnea in primary care. His Jacox III-B study administered the BQ to 744 respondents, 100 of 
whom then underwent an overnight sleep study.  The resulting analysis concluded that the BQ, in 
this study, had an 86% sensitivity for prediction of sleep apnea (respiratory disturbance index 
RDI >5). Ahmadi et al. (2008) conducted a retrospective chart review, Jacox V-B evidence, of 
130 sleep-clinic patients to also determine the effectiveness of this widely utilized screening tool 
at SDB prediction. All patients in this review completed the BQ as well as underwent two nights 
of PSG recording. Statistical analysis resulted in the BQ having moderate specificity and low 
sensitivity in correctly diagnosing sleep apnea.  The authors noted that their findings differed 
from those of Netzer et al. (1999) and that the retrospective nature of the study was indeed a 
limitation.  
Ramachandran & Josephs (2009) conducted a meta-analysis of multiple screening tests 
for obstructive sleep apnea.  This study, of the highest Jacox level, found the Berlin 
Questionnaire to be one of the most accurate questionnaires, however, a high number of false 
negatives were found with all screens, including the BQ, and most clinical prediction models. 
The least accurate screen was determined to be the ESS due to the plethora of other causative 
factors for daytime sleepiness. The STOP questionnaire, and STOP-Bang model were considered 
the simplest to use and score. Lastly, a systematic review of obstructive sleep apnea screening 
questionnaires by Abrishami, Khajehdehi & Chung (2010) reviewed 10 studies (n=1,484 
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patients) aimed at screening for SDB. The researchers concluded that such screening tools are 
associated with promising but inconsistent results due largely in part to the heterogeneous design 
of the research.  
Synthesis of the Evidence 
A review of the literature and critical appraisal of the discovered research supports the 
need for screening, diagnosis, and treatment of sleep-disordered breathing in the heart failure 
population. Untreated severe SDB has been found to have a statistically significant increased risk 
of all cause mortality (p < 0.01; Young et al., 2008), thus treatment is warranted, especially in 
patients with a confounding disease such as heart failure. Although using an overnight 
polysomnography (PSG) study in a sleep lab is considered the gold standard for diagnosis of 
sleep-disordered breathing (Jureyda & Shucand, 2004), such a study can be time-consuming and 
costly. Evidence-based screening tools such as The Epworth Sleepiness Scale (ESS) (Appendix 
2), which measure subjective daytime sleepiness, or The STOP-Bang Questionnaire (Appendix 
3), which assesses risk factors for obstructive sleep apnea, could be used to ferret out those at 
highest risk for sleep-disordered breathing in the heart failure population.  
Despite the research consensus that such screens have noted inconsistencies and a high 
rate of false-positive results (Ahmadi, Chung, Gibbs, & Shapiro, 2008; Farney, Walker, Farney, 
Snow, & Walker, 2011; Rosenthal & Dolan, 2008), when used in conjunction with a secondary 
screen of higher sensitivity and specificity such as overnight oximetry (Chung et al., 2012; 
Sommermeyer, Zou, Grote, & Hedner, 2012), identification of patients with a true diagnosis of 
sleep apnea becomes more favorable. Those patients could then be referred for a PSG study to 
confirm or refute the suggestion of sleep apnea in light of a positive, multi-leveled screen. 
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Garner & Traverse (2014) implemented such an evidence-based protocol to screen for sleep 
apnea in a heart failure disease management clinic.  
This practice project used a sleep apnea screening questionnaire, the Epworth Sleepiness 
Scale (ESS), and a less costly overnight pulse oximetry test to screen for sleep apnea in a heart 
failure clinic. The results were significantly favorable in diagnosing apnea, after confirmation by 
PSG, in their patient population when compared to using the ESS alone (Garner & Traverse, 
2014). Utilizing a screening protocol such as this for all patients diagnosed with heart failure 
would be not only feasible, but also clinically beneficial and cost effective.  
Theoretical Framework 
The Health Belief Model was chosen due to literature review findings that noted lack of 
patient compliance or non-adherence to SDB diagnostic testing and/or prescribed treatment as a 
significant challenge in the treatment of SDB in the HF patient population (Traverse, 2011). This 
model was originally developed in the 1950’s by a group of U.S. Public Health Service social 
psychologists in response to a lack of societal participation in disease detection and prevention 
programs (Health Belief Model "HBM," 2013). It is one of the first theories of health behavior 
and was later expanded to examine a person’s response, behavior, and compliance to healthcare-
related recommendations. Exploring the relationship between belief and behavior illuminates the 
path to understanding noncompliance and thus aides in predicting not only health behavior 
change but also ultimately compliance (Champion & Skinner, 2008; "HBM," 2013).  
 Six major constructs comprise the foundation of the Health Belief Model: perceived 
susceptibility, perceived severity, perceived benefits, perceived costs or barriers, motivation or 
cues to action, and lastly perceived self-efficacy. Other variables, termed modifying factors, 
include age, gender, ethnicity, personality, socioeconomics, and knowledge (Champion & 
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Skinner, 2008).  Application of this health behavior theory involves the use of goal setting, 
verbal reinforcement, and demonstration of positive behaviors. Utilization of a theoretical 
framework such as Health Belief Model will help identify HF patients at greatest risk for non-
compliance with testing and/or treatment and allow for provider education as well as 
individualization of the plan based on identified barrier(s) to help increase adherence and 
optimize outcomes.  
Project Description, Implementation, and Monitoring 
Setting, Community, and Gap Analysis 
The heart failure clinic at an urban medical center in Hartford, CT will be venue for this 
quality improvement (QI) project. The cardiology center of excellence at this medical center is 
inclusive of the heart failure clinic at which this project will be conducted. Hartford, the capitol 
of Connecticut, is a large city with a population of about 125,000. According to the United States 
Census Bureau for the year 2010, Hispanic or Latino comprised 43.4% of the city’s population, 
Black or African American 38.7%, White 15.8%, and other 2.1%.  
The hospital serves not only its home city, but also Hartford County, which has an 
estimated population of 898,000. Unlike the city of Hartford, Hartford County has a larger White 
population (64.2%) than Hispanic (16.6%) or Black (15%) (United States Census Bureau 
website, 2014).  The hospital, in regard to its emergency services and inpatient population, 
reflects a racial and ethnic composition more similar to that of the city, whereas the heart failure 
clinic more closely reflects that of the county and the intrinsic prevalence of the disease itself. 
Population-based estimates of prevalence, incidence, and prognosis of heart failure are 
lacking due to differences in study definitions of not only the condition, but also methods used to 
define the presence of the disease.  Thus, the magnitude of the problem of HF cannot be 
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accurately assessed. Regardless of the defining terms used, the prevalence of HF and LV 
dysfunction increase significantly with age, and the prevalence in African-Americans is stated to 
be 25% higher than in Whites. This is due, in part, to a higher prevalence of predisposing 
conditions for HF that are most often diagnosed in the African American population. There has 
been a shift over the past four decades in regard to the primary causes of HF from hypertension 
and coronary artery disease (CAD) to that of CAD and diabetes mellitus as seen in the 
Framingham Study. CAD prevalence as a cause in men increased 41% per calendar decade and 
25% in women with diabetes as a contributing cause in both sexes increasing by more than 20% 
per decade. Racial differences in HF risk factors revealed that among blacks, a greater proportion 
of HF risk was due to modifiable risk factors such as elevated systolic BP, elevated fasting 
glucose levels, CAD, LV hypertrophy, and smoking. (Vasan & Wilson, 2013) 
Education, not only intrinsic education, but ongoing disease education, plays a large 
factor in addressing not only the modifiable risk factors for HF as a disease, but also for the 
ongoing need for diligent disease management and follow-up critical for patients within this 
population. Census data shows that those with a Bachelor’s degree or higher at age 25+ for 
Hartford County for years 2009-2013 are 34.9% whereas those in Harford, the city, are 15.2% 
with the state average being 36.5% (United States Census Bureau website, 2014).  
Practitioners need to have an understanding of their patient population in regard to not 
only racial and ethnic make-up but also educational level and need for educational support for 
proper disease treatment, management, and compliance. The patients that frequent the heart 
failure clinic at Saint Francis Hospital are representative of city, county, and disease prevalence 
populations, with perhaps a slightly higher incidence of African American patients than other 
ethnicities/races.  
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Organizational Analysis of Project Site 
The HF clinic team consists of two MDs, ten PA/APRNs, four RNs, and an 
administrative director. Together, this team provides complete care for both clinic outpatients as 
well as heart failure patients currently being treated on the CHF inpatient unit. The inpatient unit 
is staffed by additional RNs employed by the medical center. Provider support is available to 
these patients, both inpatient and outpatient, around the clock. The clinic reports to the 
cardiovascular service line dyad, a medical executive who represents the inpatient aspect, as well 
as an administrative executive representing the outpatient component of the clinic.  
Evidence of Stakeholder Support 
The internal stakeholders of this project include both physicians responsible for the care 
of the HF patients who seek care for their disease management at this hospital-based clinic. The 
medical director requested the institution of a sleep apnea screen based on current research 
evidence for all patients seen at the clinic. All the providers at the clinic support his request for 
such a screening tool. Currently, sleep apnea screening does not exist for this patient population 
at either the outpatient or inpatient level. Screening and treatment were only occurring if HF 
patients had it with other healthcare providers.  The DNP candidate met with not only the heart 
failure team to discuss ideas for implementation of a complete screening protocol. Providers 
agreed to implement a multi-phased approach for instituting this newly desired protocol at both 
the outpatient and inpatient levels of care.  The project involved assisting the team with phase 
one of a projected four-phase plan to adopt a routine SDB screening protocol for the heart failure 
population served at this facility.  
 
 
SCREENING FOR SLEEP APNEA  17 
 
Facilitators, Barriers, and Constraints 
As with any new protocol, both facilitators and barriers to implementation success exist. 
A strong evidence-base supports the use of PAP as a treatment for sleep apnea in the HF patient 
and lends to provider credibility when educating patients on the need for treatment compliance. 
The simplicity of the screening tool(s) for healthcare staff to administer and score as well as the 
ease of home nocturnal oximetry evaluation for the patient enhances acceptance of the screen by 
both administrators and patients alike. Out-of-pocket costs to implement sleep apnea screening in 
the office setting are minimal for both providers and patients. Additionally, healthcare insurance 
companies are more likely to cover the cost of polysomnography in the presence of an oximetry 
study indicative of periods of hypoxia.  
Barriers to implementation are few, but exist. Obtaining either a clinic-owned home 
oximetry screening system or finding a corporation to provide this service is the greatest hurdle. 
This part of the screening protocol is significant to diagnosing those patients with central sleep 
apnea that will often not screen positive on the various obstructive sleep apnea/ESS screening 
tools to be evaluated during this project. Patient non-compliance is the largest barrier to protocol 
evaluation and treatment success. 
 Garner & Traverse (2013) studied the health behaviors and sleep apnea treatment 
adherence in the HF patient. They found that non-compliance was highest in the elderly and in 
women for various reasons such as the prospect of an overnight sleep study outside of the home, 
being “too old” for evaluation and treatment, complications with other diagnoses, and cost. For 
those who underwent PSG evaluation but did not comply with the recommended PAP treatment, 
reasons of mask intolerance, claustrophobia, and drying of the nose were given (Garner & 
Traverse, 2013).  
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Project Design and Methods 
Instituting a complete and reliable SDB screening protocol for a HF program of this size 
is a large task. Thus, implementation was divided into four phases: choosing a written screening 
tool, obtaining the ability to provide overnight oximetry studies, implementing the two-part 
screening protocol on all clinic patients per inclusion/exclusion criteria, and screening inpatients 
for SDB while hospitalized if not previously documented. This project focused on facilitating 
phase one of this multi-phased project. 
Using a set of screening tools similar to those used by Garner & Traverse (2014), the 
project goal was to screen adult patients with a diagnosis of heart failure, NYHA class I-IV, not 
currently diagnosed with or being treated for any form of sleep-disordered breathing. Parameters 
for determination of a positive screen were outlined in advance, and patients that met or 
exceeded these values would be referred to a sleep specialist to undergo PSG studies to confirm 
or refute the suspicion of SDB. For example, an ESS score of 9 or greater and/or a nocturnal 
desaturation of 89% or less for a total of five minutes or more would qualify for PSG (Garner & 
Traverse, 2014). Those patients found to have an AHI confirming sleep apnea would then be 
recommended for positive airway pressure (PAP) treatment for the newly diagnosed condition. 
Patient education throughout the screening and/or treatment process is key to attaining 
compliance. Use of the HBM to examine patient perceptions and health beliefs to guide 
additional teaching points is essential.  
Using evidence-based research, three screening tools were determined to be effective in 
screening for SDB.  For phase one of this QI project, five providers, one MDs and three APRNs, 
and one RN used and evaluated the three tools. The DNP candidate gave five copies of each 
screening tool to be evaluated to each one of the HF clinic providers.  They then used the three 
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tools to screen 15 patients for sleep apnea following the inclusion criteria of the project. Patients 
were qualified to be screened if they were 18 years or older, had a documented diagnosis of heart 
failure, NYHA stage II or more, and had not been diagnosed with or treated for sleep apnea in 
the past. Once all 75 patients were screened, the DNP student had the providers complete a 
written evaluation of the tools used (Appendix 4). The next step involved individual meetings 
with the providers privately to discuss the pros and cons of each screening tool trialed.  A group 
meeting was also scheduled to discuss the overall results and opinions of phase one as well as to 
potentially decide which one or two screening tools will become part of the screening protocol.  
Phases two through four will be completed after this project, however, the DNP candidate 
will assist with facilitating the progression of these advanced stages and support the providers in 
continued refinement and development during the time spent in clinic for phase one. Obtaining 
the ability to provide overnight oximetry studies is an integral part of the proposed screen.   
 Begin End Goal(s) 
Phase II 
Obtain Oximetry April 2015 June 2015 
Obtain overnight 
oximetry equipment. 
Phase III 
Implement Full 
Protocol 
June 2015 June 2016 
Screen all new HF 
clinic patients. 
 
Refer high-risk 
patients for PSG and 
confirm diagnosis. 
 
Use HBM as 
foundation for patient 
education regarding 
treatment of sleep 
apnea. 
Phase IV 
Inpatient Screening 
December 2015 June 2016 
Educate unit staff and 
screen inpatients. 
 
Refer high-risk 
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patients for PSG and 
confirm diagnosis. 
 
Follow-up in HF 
clinic post-discharge. 
 
Goals, Objectives, and Expected Outcomes 
Identifying comorbidities that negatively impact the morbidity and mortality of 
cardiovascular disease, namely heart failure, and mitigating them with evidence-based treatment 
is essential to providing holistic care to patients at risk. In most settings, HF patients are not 
routinely screened for SDB (Khayat et al., 2013), so any positive screen that resulted in treatment 
otherwise not prescribed would be considered effective.  
The long-term goal of this project is to design and implement a sleep apnea screening 
protocol for heart failure patients treated at an urban medical center heart failure clinic. The 
short-term goal is to select a sleep apnea screening questionnaire(s) for use in the protocol.  
The objectives of the project as a whole are as follows: 
• Identify HF patients at risk for sleep apnea using screening questionnaires and oximetry 
studies. 
• Refer at-risk patients identified for PSG study to confirm or refute diagnosis of sleep 
apnea. 
• Educate patients and providers on the need for screening and treatment of sleep apnea in 
the HF population. 
• Initiate treatment for patients diagnosed with sleep apnea using PAP as prescribed by a 
pulmonologist. 
• Improve patient wellness by minimizing symptoms associated with sleep apnea and 
improving cardiac function. 
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The expected outcome for this project is the successful selection of a screening tool(s) by 
the clinic providers to be used in the sleep apnea screening protocol. 
Protection of Human Subjects 
Institutional Review Board (IRB) approval was not required for this project as it was a 
quality improvement project.  Assigning numbers to designate each patient protected the 
confidentiality of all participants during data collection and analysis.  Information collected 
consisted of the data required by the various screening tools, such as age, gender, neck 
circumference, height, and weight and was not linked with personal identifiers of participants. 
Although the screening tools were reviewed and re-scored by the DNP student for accuracy of 
use and frequency of positive screens, patient identification was not necessary and thus no risk to 
patient confidentiality occurred.   
Implementation and Data Collection 
Providers were educated as to both the short-term goals related to this project, as well as 
the long-term goal of the institution of a sleep apnea screening protocol for the HF clinic. The 
three screening tools to be evaluated were distributed to each provider and returned to the DNP 
candidate for scoring check, patient chart review, and inclusion validation. Providers were 
expected to screen 15 patients each for a total of 75 patients screened and then complete the 
provider feedback form (Appendix 4). Data about each screening tool was assessed including 
number of screens completed, positive screens per tool, gender ratios, and provider feedback. 
The data was compiled, reviewed, and charted for presentation to the provider group at project 
end.  
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Evaluation 
Results, Findings, and Data Analysis 
Five providers, an MD, three PAs, and an RN, were asked to participate in evaluating the 
three screening tools, ESS, STOP-BANG questionnaire, and Berlin questionnaire.  Each tool was 
to be used to screen five patients for an anticipated screening database of 75 patients. At project 
end, 17 out of a targeted 75 patients were screened for 23% of goal. All patients screened, ten 
males and seven females, met the inclusion criteria set forth by the DNP student as verified by 
chart audit.  
Table I. Completed Screening Tools 
Tool Anticipated Screens Actual Screens Percent Received 
ESS 25 7 28% 
STOP-BANG 25 4 16% 
Berlin 25 6 24% 
TOTAL SCREENS 75 17 23% 
 
Of the 17 patients screened, eight patients (47%) scored as being “high risk” for sleep 
apnea according to the scoring guidelines of each tool. Table II outlines each screen’s gender 
demographics and positive results by tool.  
Table II. Positive Apnea Screens by Gender and Tool 
 ESS STOP-BANG Berlin TOTAL 
Male Positive 3 2 0 5 
Female Positive 0 1 2 3 
Percent Positive 43% 75% 33% 47% 
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Two of the five providers completed and submitted the Screening Tool Feedback Form. 
Each tool was rated using a 1-5 scale (whereas 1 = poor and 5 = superior) in three categories for 
a potential score of 3-15.  
Table III. Provider Rating of Each Tool 
 ESS STOP-BANG Berlin 
Provider 1 15/15 10/15 12/15 
Provider 2 14/15 8/15 11/15 
 
Both responding providers scored ESS as superior and commented that its ease of use, 
sensitivity, and lack of needed “measurements” influenced their opinion.  
Despite the small sample size, the results of this preliminary sleep apnea screening trial 
closely mirror the findings of not only the CDC but also various research studies that place the 
incidence of sleep apnea in heart failure patients at 50-80% (Kasai & Bradley, 2011). The tool of 
choice to be used in conjunction with overnight oximetry in the full protocol, Epworth 
Sleepiness Scale, meets the criteria for an ideal screening device as described by Pang & Terris 
(2006), “…cheap, readily accessible, easily used with minimal instructions, have no risk of side 
effects to the patient, and be safe and accurate”. Confirmation of suspected diagnosis through 
PSG, the gold standard, has proven this screening protocol to be an effective method for 
identifying and diagnosing sleep apnea in the heart failure population (Garner & Traverse, 2014).  
Once the long-term goal of complete protocol screening has been implemented and 
treatment ordered and instituted, long-term compliance with sleep apnea treatment can be 
reinforced by noting the patients verbalization of improved symptoms, improved ESS, BQ, or 
STOP-Bang scores, or by means of repeat echocardiogram (ECHO) which could possibly show 
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documented improvement of heart function. Trending the data over time (monthly, quarterly, 
yearly) to determine compliance rates is necessary so that providers can customize treatment 
programs and reinforce disease education to increase the self-efficacy construct noted in HBM to 
overcome these barriers. Follow-up at routine intervals, especially in the first two weeks of PAP 
treatment, to monitor patient response, tolerance, compliance, and subjective reporting is 
necessary.  Encouraging the use of support groups is also recommended (Garner & Traverse, 
2013). 
Discussion and Conclusion 
This capstone project was designed to be the first phase of a multi-phased sleep apnea 
screening protocol for a busy urban heart failure clinic. The goal was to evaluate and select an 
evidence-based sleep apnea screening questionnaire for use in the larger sleep apnea screening 
protocol. After providers used the selected tools, completed the feedback form, and met as a 
group for open discussion, the Epworth Sleepiness Scale was chosen as the screening tool to be 
used in the full screening protocol to be implemented in the near future. Providers stated ease of 
use, patient autonomy in completion, and screening sensitivity as factors for this choice.  
The implementation and use of this tool, in conjunction with overnight pulse oximetry 
studies for those who are scored as “high risk”, will lay the solid foundation for the gold-
standard polysomnography study and absolute diagnosis of patients with a sleep disordered 
breathing condition. Health Belief Model can then be used to guide patient teaching, readiness to 
learn, barriers to treatment compliance, and self-efficacy for action. HBM allows healthcare 
providers to predict why individuals engage in behavior change to prevent, detect, or treat a 
diagnosed condition or disease (Champion & Skinner, 2008). The focus on self-efficacy, the 
confidence in one’s own abilities to engage in a treatment, is important not only as an indicator 
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of health outcomes but also as a means by which nurse educators can improve patient’s quality 
of life.  
Sleep apnea in the heart failure population should be approached as a coexisting chronic 
disease requiring long-term multidisciplinary management (Khayat et al., 2013). Unfortunately, 
sleep apnea is not part of the routine evaluation and management of heart failure, so it remains 
untreated in most patients.  Nursing can play an instrumental role in screening and identifying 
those patients at highest risk for sleep apnea using an evidence-based screening protocol. Once 
identified and diagnosed, nurse educators can implement the principles and knowledge of HBM 
to construct an individualized educational plan to increase adherence with recommended 
therapies, spawn cues to action, and increase patient awareness.  The resulting compliance to 
treatment greatly impacts quality of life, disease progression, and ultimately morbidity and 
mortality (Kazimierczak, Krzesinski, Krzyzanowski, & Gielerak, 2013).  
Limitations 
The lack of full provider participation and evaluation of selected tools limited the “real-
use” input during the round-table discussion regarding tool choice/preference for use in the 
larger protocol.  Additionally, the short timeframe of the project limited implementation to phase 
one only and disallowed for evaluation of the multi-faceted screening protocol and ability to 
attain true diagnostic confirmation via gold-standard testing, thus gaining insight as to the 
sensitivity and specificity of the protocol design.   
Plan for Post-Project Continuation 
The heart failure clinic that served as the site for this capstone project will continue with 
phases two through four of the implantation of a SDB screening protocol for both the inpatient 
heart failure unit and the affiliated outpatient heart failure clinic.  An overnight pulse oximetry 
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study will be ordered and completed for patients who score as “at risk” on the chosen sleep 
apnea screening tool. Oxygen desaturation associated with periods of apnea can be rudimentarily 
detected via this study. The true AHI (apnea-hypopnea index) is then determined by 
polysomnography, a full overnight sleep study, which can then be ordered for patients exhibiting 
episodes of hypoxia. Inpatients deemed at risk can also undergo oximetry study during their 
hospitalization if not previously diagnosed or ruled-out for sleep apnea. The goal for full 
implementation of such comprehensive sleep-disordered breathing screening protocol is 
projected for the end of 2015. Ongoing education of all staff not only on newly instituted 
screening protocols but also HBM theory and patient compliance will aide in project success.  
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Appendix 4 
Screening Tool Feedback Form 
Please rate using 1-5 scale whereas 1 = poor; 5 = superior 
Epworth Sleepiness Scale:  
1) Patient friendly: ___________________ 
2) Provider friendly: __________________ 
3) Ease of use/scoring: ________________ 
4) Pros/cons: _________________________________________________________ 
Stop-BANG Questionnaire:  
1) Patient friendly: ___________________ 
2) Provider friendly: __________________ 
3) Ease of use/scoring: ________________ 
4) Pros/cons: _________________________________________________________ 
Berlin Questionnaire 
1) Patient friendly: ___________________ 
2) Provider friendly: __________________ 
3) Ease of use/scoring: ________________ 
4) Pros/cons: _________________________________________________________ 
What tool or tools do you think would BEST be suited to aide in screening your 
patients for sleep-disordered breathing and why?__________________________ 
____________________________________________________________________  
____________________________________________________________________  
____________________________________________________________________ 
